Latest by Sony Salzman
Dolutegravir More Effective Than Efavirenz at Achieving Viral Suppression During Late-Term Pregnancy, New Study Shows
Unlike some previous studies that focused on early pregnancy, this study showed no associated congenital disabilities with either drug.
Prior studies have indicated that hepatitis C direct-acting antivirals reduce the risk of hepatocellular carcinoma, but this is the first large prospective study to compare outcomes among treated and untreated patients.
TheBodyPro is covering all the latest in HIV science at the biggest annual gathering of HIV researchers in the U.S. Here's a preview of what's to come.
New scientific evidence suggests that the celebrity-backed diet may have significant cognitive benefits for older people living with HIV.
A presentation at the recent conference of the Association of Nurses in AIDS Care (ANAC 2018) looked at the use of video consultations and remote diagnostics in prisons to deliver high-quality health care.
Bridgette Brawner, Ph.D., APRN, was recently honored for her research on heterosexually active black teens with mental illness -- a group that's under-represented in HIV prevention campaigns.
Kistin Nolan, M.P.H., and colleagues helped pilot a retention program designed to accommodate the emotional turmoil that makes it more difficult for young people with HIV to successfully navigate the health care system.
"We're already triaging people," said Kara Vassily, RN, "so for us, this is another series of things we can do to get the rapid HIV and hepatitis C screening done."
What are the benefits and risks of marijuana use for people living with HIV? The answer is complicated, and explains why clinician-patient communication on the issue is increasingly important.
On the surface, a 1.1 million drop in the prevalence of hepatitis C in the U.S. would seem to signal a major victory for the advances made in hepatitis C treatment this decade. But the reality is considerably more complex.